Oncogene inactivation in a mouse model
- 1 August 2000
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 406 (6795), 473-474
- https://doi.org/10.1038/35020190
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Maxizymes, Novel Allosterically Controllable Ribozymes, Can Be Designed To Cleave Various SubstratesBiomacromolecules, 2000
- tRNA Val -heterodimeric maxizymes with high potential as geneinactivating agents: Simultaneous cleavage at two sites in HIV-1 tat mRNA in cultured cellsProceedings of the National Academy of Sciences, 1999
- A Novel Allosterically trans-Activated Ribozyme, the Maxizyme, with Exceptional Specificity In Vitro and In VivoMolecular Cell, 1998
- Formation of a catalytically active dimer by tRNAVal -driven short ribozymesNature Biotechnology, 1998
- Hammerhead Minizymes with High Cleavage Activity: A Dimeric Structure as the Active Conformation of MinizymesJournal of the American Chemical Society, 1996
- Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor ProgramBlood, 1993
- Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitroScience, 1992
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activityCell, 1984
- Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemiaNature, 1983